Table 4. Characteristics of included studies from India.
| ## | Author | Year | Institution | City | Study cohort | Tissue type | Technique | Total PTC | BRAF+ | BRAF rate (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chakraborty A (120) | 2012 | Tata Memorial Hospital | Mumbai | 2002–2006 | Fresh frozen | PCR + Seq | 86 | 46 | 53 |
| 2 | Khan MS (121) | 2014 | Sher-I-Kashmir Institute of Medical Sciences | Srinagar | 2010–2012 | FFPE | PCR | 42 | 15 | 36 |
| 3 | Agarwal S (122) | 2016 | All India Institute of Medical Sciences | New Delhi | 2015–2016 | FFPE | Seq | 40 | 19 | 48 |
| 4 | Nair CG (123) | 2017 | Amrita Institute of Medical Sciences | Kochi | 2012 | FFPE | PCR | 59 | 30 | 51 |
| 5 | Ahmad F (124) | 2018 | Research and Development Division of SRL | Mumbai | n/s | FFPE | PCR + Seq | 70 | 35 | 50 |
| 6 | Fonseca D (125) | 2018 | Basavatarakam Indo American Cancer Hospital | Telangana | 2015–2018 | FFPE | IHC | 23 | 11 | 48 |
| 7 | George N (126) | 2018 | Sanjay Gandhi Postgraduate Institute | Lucknow | 2000–2014 | FFPE | PCR | 109 | 56 | 51 |
| 8 | Hemalatha R (127) | 2018 | Christian Medical College | Vellore | n/s | FNA | Seq | 53 | 19 | 36 |
| 9 | Krishnamurthy A (128) | 2018 | Cancer Institute (WIA) | Chennai | 2005–2006 | FFPE | IHC + qPCR | 79 | 25 | 32 |
IHC, immunohistochemistry; FFPE, formalin fixed paraffin embedded tissues; FNA, fine needle aspiration; n/s, not specified; qPCR, quantitative polymerase chain reaction; Seq, sequencing